Antiemetics Commonly Prescribed in Children Undergoing Dental Treatment Under General Anaesthesia- A Retrospective Cohort Study
Abstract
Background: Postoperative nausea and vomiting (PONV) are the most widely recognized unfavorable impact of pediatric anaesthesia and medical procedure Numerous antiemetic drugs are utilized for preventive treatment. They have different biochemical collaborations and inconveniences, yet there is still a weakness about which drugs are best with the least side effects. Aim: The aim of the current study is to find the antiemetics commonly prescribed in children undergoing dental procedures in general anaesthesia. Materials and Methods: The retrospective study was led in a private dental school, Chennai, India. Moral endorsement was obtained from the Institutional audit board before the beginning of the review. Information was gathered from DIAS (Dental Information Archiving Software) and the board framework records of the children under 18 years old who were treated under broad anaesthesia between September 2020 and February 2021 which was placed in the systemic way. A comfort test of 100 children going through dental treatment under general anaesthesia who were endorsed with antiemetics were remembered for the review. Information gathered with following boundaries like age, gender, antiemetics given. The classification of information was done in excel sheets and imported to SPSS. Results: Among 100 children treated under general anaesthesia, 56 were males and 44 were females. As a total count male were higher with a percentage of 56% when compared to females with 44%. 65% of…
Read the paper
Related studies
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations
- Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.